Arvind M. Hundal
Inversor de Capital Privado en Accelerace Management A/S .
Perfil
Arvind M.
Hundal is a professional with a doctorate degree from the University of Glasgow and an undergraduate degree from King's College London.
She is currently working as a Business Accelerator & Investment Manager at Accelerace Management A.
Previously, she worked as the Chief Business Officer at Zealand Pharma A from 2009 to 2011 and as the Chief Business Officer at Ziarco Pharma Ltd.
Cargos activos de Arvind M. Hundal
| Empresas | Cargo | Inicio |
|---|---|---|
Accelerace Management A/S
 Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Inversor de Capital Privado | 01/04/2017 |
Antiguos cargos conocidos de Arvind M. Hundal.
| Empresas | Cargo | Fin |
|---|---|---|
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Corporate Officer/Principal | 01/02/2017 |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
Formación de Arvind M. Hundal.
| King's College London | Undergraduate Degree |
| University of Glasgow | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Accelerace Management A/S
Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Finance |
- Bolsa de valores
- Insiders
- Arvind M. Hundal
